DOI:
10.1055/s-00000145
Dialyse aktuell
LinksClose Window
References
Mysler EF, Spindler AJ, Guzman R. et al
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.
Arthritis Rheum 2013;
65: 2368-2379 doi:10.1002/art.38037
We do not assume any responsibility for the contents of the web pages of other providers.